Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers - PubMed (original) (raw)
. 2010 Jul 1;172(1):81-93.
doi: 10.1093/aje/kwq120. Epub 2010 Jun 18.
Eric J Jacobs, Alan A Arslan, Dai Qi, Alpa V Patel, Kathy J Helzlsouer, Stephanie J Weinstein, Marjorie L McCullough, Mark P Purdue, Xiao-Ou Shu, Kirk Snyder, Jarmo Virtamo, Lynn R Wilkins, Kai Yu, Anne Zeleniuch-Jacquotte, Wei Zheng, Demetrius Albanes, Qiuyin Cai, Chinonye Harvey, Richard Hayes, Sandra Clipp, Ronald L Horst, Lonn Irish, Karen Koenig, Loic Le Marchand, Laurence N Kolonel
Affiliations
- PMID: 20562185
- PMCID: PMC2892543
- DOI: 10.1093/aje/kwq120
Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers
Rachael Z Stolzenberg-Solomon et al. Am J Epidemiol. 2010.
Abstract
Results from epidemiologic studies examining pancreatic cancer risk and vitamin D intake or 25-hydroxyvitamin D (25(OH)D) concentrations (the best indicator of vitamin D derived from diet and sun) have been inconsistent. Therefore, the authors conducted a pooled nested case-control study of participants from 8 cohorts within the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers (VDPP) (1974-2006) to evaluate whether prediagnostic circulating 25(OH)D concentrations were associated with the development of pancreatic cancer. In total, 952 incident pancreatic adenocarcinoma cases occurred among participants (median follow-up, 6.5 years). Controls (n = 1,333) were matched to each case by cohort, age, sex, race/ethnicity, date of blood draw, and follow-up time. Conditional logistic regression analysis was used to calculate smoking-, body mass index-, and diabetes-adjusted odds ratios and 95% confidence intervals for pancreatic cancer. Clinically relevant 25(OH)D cutpoints were compared with a referent category of 50-<75 nmol/L. No significant associations were observed for participants with lower 25(OH)D status. However, a high 25(OH)D concentration (> or =100 nmol/L) was associated with a statistically significant 2-fold increase in pancreatic cancer risk overall (odds ratio = 2.12, 95% confidence interval: 1.23, 3.64). Given this result, recommendations to increase vitamin D concentrations in healthy persons for the prevention of cancer should be carefully considered.
Figures
Figure 1.
Forest plots for meta-analysis of the association between circulating 25-hydroxyvitamin D (25(OH)D) concentrations and risk of pancreatic cancer within the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers, 1974–2006. Odds ratios (squares) and 95% confidence intervals (bars) were derived from conditional logistic regression models adjusted for body mass index (weight (kg)/height (m)2) in World Health Organization categories (<18.5, 18.5–<25.0, 25.0–30.0, 30.0–<35.0, or ≥35.0, or missing data), smoking (never smoker, former smoker who had quit ≥15 years previously, former smoker who had quit 1–14 years previously, former smoker who had quit <1 year previously or current smoker of <20 cigarettes/day, and former smoker who had quit <1 year previously or current smoker of ≥20 cigarettes/day), and diabetes status (yes, no, or missing data). The size of each square is inversely proportional to the variance of the log odds ratio estimate in each cohort. The pooled estimates (diamonds) were derived from a meta-analysis using random-effects modeling. For each cohort, the plots show estimates for subjects with circulating 25(OH)D concentrations of A) <25 nmol/L and B) ≥100 nmol/L in comparison with the reference group (50–<75 nmol/L). ATBC, Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study, CI, confidence interval; CPS-II, Cancer Prevention Study II Nutrition Cohort; MEC, Multiethnic Cohort Study; NYU-WHS, New York University Women's Health Study; OR, odds ratio; PLCO, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; SM/WHS, Shanghai Men's Health Study and Shanghai Women's Health Study. SM/WHS data were excluded from the analysis of high 25(OH)D concentrations because of unstable estimates due to small numbers.
Comment in
- Re: "circulating 25-hydroxyvitamin d and risk of pancreatic cancer".
Krstic G. Krstic G. Am J Epidemiol. 2011 Feb 15;173(4):476; author reply 476-7. doi: 10.1093/aje/kwq430. Epub 2011 Jan 12. Am J Epidemiol. 2011. PMID: 21228413 Free PMC article. No abstract available.
Similar articles
- Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Gallicchio L, Helzlsouer KJ, Chow WH, Freedman DM, Hankinson SE, Hartge P, Hartmuller V, Harvey C, Hayes RB, Horst RL, Koenig KL, Kolonel LN, Laden F, McCullough ML, Parisi D, Purdue MP, Shu XO, Snyder K, Stolzenberg-Solomon RZ, Tworoger SS, Varanasi A, Virtamo J, Wilkens LR, Xiang YB, Yu K, Zeleniuch-Jacquotte A, Zheng W, Abnet CC, Albanes D, Bertrand K, Weinstein SJ. Gallicchio L, et al. Am J Epidemiol. 2010 Jul 1;172(1):10-20. doi: 10.1093/aje/kwq116. Epub 2010 Jun 18. Am J Epidemiol. 2010. PMID: 20562188 Free PMC article. - Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
McCullough ML, Weinstein SJ, Freedman DM, Helzlsouer K, Flanders WD, Koenig K, Kolonel L, Laden F, Le Marchand L, Purdue M, Snyder K, Stevens VL, Stolzenberg-Solomon R, Virtamo J, Yang G, Yu K, Zheng W, Albanes D, Ashby J, Bertrand K, Cai H, Chen Y, Gallicchio L, Giovannucci E, Jacobs EJ, Hankinson SE, Hartge P, Hartmuller V, Harvey C, Hayes RB, Horst RL, Shu XO. McCullough ML, et al. Am J Epidemiol. 2010 Jul 1;172(1):21-35. doi: 10.1093/aje/kwq113. Epub 2010 Jun 18. Am J Epidemiol. 2010. PMID: 20562191 Free PMC article. - Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
Zeleniuch-Jacquotte A, Gallicchio L, Hartmuller V, Helzlsouer KJ, McCullough ML, Setiawan VW, Shu XO, Weinstein SJ, Weiss JM, Arslan AA, De Vivo I, Gao YT, Hayes RB, Henderson BE, Horst RL, Koenig KL, Patel AV, Purdue MP, Snyder K, Steplowski E, Yu K, Zheng W, Hankinson SE. Zeleniuch-Jacquotte A, et al. Am J Epidemiol. 2010 Jul 1;172(1):36-46. doi: 10.1093/aje/kwq114. Epub 2010 Jun 18. Am J Epidemiol. 2010. PMID: 20562189 Free PMC article. - Effectiveness and safety of vitamin D in relation to bone health.
Cranney A, Horsley T, O'Donnell S, Weiler H, Puil L, Ooi D, Atkinson S, Ward L, Moher D, Hanley D, Fang M, Yazdi F, Garritty C, Sampson M, Barrowman N, Tsertsvadze A, Mamaladze V. Cranney A, et al. Evid Rep Technol Assess (Full Rep). 2007 Aug;(158):1-235. Evid Rep Technol Assess (Full Rep). 2007. PMID: 18088161 Free PMC article. Review. - Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts.
Stolzenberg-Solomon RZ, Newton CC, Silverman DT, Pollak M, Nogueira LM, Weinstein SJ, Albanes D, Männistö S, Jacobs EJ. Stolzenberg-Solomon RZ, et al. Am J Epidemiol. 2015 Aug 1;182(3):187-97. doi: 10.1093/aje/kwv041. Epub 2015 Jun 17. Am J Epidemiol. 2015. PMID: 26085045 Free PMC article. Review.
Cited by
- The association between circulating 25-hydroxyvitamin D and pancreatic cancer: a systematic review and meta-analysis of observational studies.
Shen Y, Xia J, Yi C, Li T, Wang P, Dai L, Shi J, Wang K, Sun C, Ye H. Shen Y, et al. Eur J Nutr. 2024 Apr;63(3):653-672. doi: 10.1007/s00394-023-03302-w. Epub 2024 Jan 3. Eur J Nutr. 2024. PMID: 38170272 Review. - On the Menu: Analyzing the Macronutrients, Micronutrients, Beverages, Dietary Patterns, and Pancreatic Cancer Risk.
Mukhtar S, Moradi A, Kodali A, Okoye C, Klein D, Mohamoud I, Olanisa OO, Parab P, Chaudhary P, Hamid P. Mukhtar S, et al. Cureus. 2023 Sep 14;15(9):e45259. doi: 10.7759/cureus.45259. eCollection 2023 Sep. Cureus. 2023. PMID: 37842365 Free PMC article. Review. - Scientific opinion on the tolerable upper intake level for vitamin D, including the derivation of a conversion factor for calcidiol monohydrate.
EFSA Panel on Nutrition, Novel Foods and FoodAllergens (NDA); Turck D, Bohn T, Castenmiller J, de Henauw S, Hirsch-Ernst KI, Knutsen HK, Maciuk A, Mangelsdorf I, McArdle HJ, Pentieva K, Siani A, Thies F, Tsabouri S, Vinceti M, Lanham-New S, Passeri G, Craciun I, Fabiani L, De Sousa RF, Martino L, Martínez SV, Naska A. EFSA Panel on Nutrition, Novel Foods and FoodAllergens (NDA), et al. EFSA J. 2023 Aug 8;21(8):e08145. doi: 10.2903/j.efsa.2023.8145. eCollection 2023 Aug. EFSA J. 2023. PMID: 37560437 Free PMC article. - The Problem of Vitamin D Scarcity: Cultural and Genetic Solutions by Indigenous Arctic and Tropical Peoples.
Frost P. Frost P. Nutrients. 2022 Sep 30;14(19):4071. doi: 10.3390/nu14194071. Nutrients. 2022. PMID: 36235726 Free PMC article. Review. - 25(OH)Vitamin D Deficiency and Calcifediol Treatment in Pediatrics.
Castano L, Madariaga L, Grau G, García-Castaño A. Castano L, et al. Nutrients. 2022 Apr 29;14(9):1854. doi: 10.3390/nu14091854. Nutrients. 2022. PMID: 35565821 Free PMC article. Review.
References
- Grant WB. An ecologic study of cancer mortality rates in Spain with respect to indices of solar UVB irradiance and smoking. Int J Cancer. 2007;120(5):1123–1128. - PubMed
- Tuohimaa P, Pukkala E, Scélo G, et al. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer. 2007;43(11):1701–1712. - PubMed
- Mizoue T. Ecological study of solar radiation and cancer mortality in Japan. Health Phys. 2004;87(5):532–538. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-CN-25524/CN/NCI NIH HHS/United States
- N01 CN25513/CN/NCI NIH HHS/United States
- N01-CN-25511/CN/NCI NIH HHS/United States
- N01-CN-75022/CN/NCI NIH HHS/United States
- N01-PC35137/PC/NCI NIH HHS/United States
- N01 CN25511/CN/NCI NIH HHS/United States
- N01 CN25524/CA/NCI NIH HHS/United States
- N01 CN25404/CN/NCI NIH HHS/United States
- P01 CA33619/CA/NCI NIH HHS/United States
- R37 CA54281/CA/NCI NIH HHS/United States
- N01 CN25515/CN/NCI NIH HHS/United States
- N01 CN25512/CN/NCI NIH HHS/United States
- ImNIH/Intramural NIH HHS/United States
- R01 CA82729/CA/NCI NIH HHS/United States
- N01 CN25522/CA/NCI NIH HHS/United States
- N01-CN-25518/CN/NCI NIH HHS/United States
- N01-CN-25513/CN/NCI NIH HHS/United States
- N02-CP-11010-66/CP/NCI NIH HHS/United States
- N01-RC-45035/RC/CCR NIH HHS/United States
- N01 CN25476/CN/NCI NIH HHS/United States
- R01 CA082729/CA/NCI NIH HHS/United States
- N01-CN-25514/CN/NCI NIH HHS/United States
- R37 CA70867/CA/NCI NIH HHS/United States
- N01-CN-25512/CN/NCI NIH HHS/United States
- R37 CA070867/CA/NCI NIH HHS/United States
- N01 CN25516/CN/NCI NIH HHS/United States
- N01PC35137/CA/NCI NIH HHS/United States
- N01-CN-25515/CN/NCI NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- P01 CA033619/CA/NCI NIH HHS/United States
- R01 CA098661/CA/NCI NIH HHS/United States
- N01-CN-25404/CN/NCI NIH HHS/United States
- N01-CN-25516/CN/NCI NIH HHS/United States
- N01 CN25514/CN/NCI NIH HHS/United States
- N01RC37004/RC/CCR NIH HHS/United States
- R01 CA105069/CA/NCI NIH HHS/United States
- N01 CN75022/CN/NCI NIH HHS/United States
- N01-CN-25476/CN/NCI NIH HHS/United States
- N01 CN045165/CN/NCI NIH HHS/United States
- N02CP11010/CP/NCI NIH HHS/United States
- R37 CA054281/CA/NCI NIH HHS/United States
- N01 CN25518/CN/NCI NIH HHS/United States
- U01 AG018033/AG/NIA NIH HHS/United States
- N01-CN-25522/CN/NCI NIH HHS/United States
- K07 CA73790/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical